« Back to Record
Citation APA

Lin, N. U., Diéras, V., Paul, D., Lossignol, D., Christodoulou, C., Stemmler, H.-J., Roche, H., Liu, C. M. H., Greil, R., Ciruelos, E., Loibl, S., Gori, S., Wardley, A., Yardley, D., Brufsky, A., Blum, J., Rubin, S. D., Dharan, B., Steplewski, K., Zembryki, D., Oliva, C., Roychowdhury, D., Paoletti, P., & Winer, E. P. (2009). Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clinical cancer research, 15(4), 1452-1459. doi:10.1158/1078-0432.CCR-08-1080


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/119821

Lin, N. U., Diéras, V., Paul, D., Lossignol, D., Christodoulou, C., Stemmler, H.-J., Roche, H., Liu, C. M. H., Greil, R., Ciruelos, E., Loibl, S., Gori, S., Wardley, A., Yardley, D., Brufsky, A., Blum, J., Rubin, S. D., Dharan, B., Steplewski, K., Zembryki, D., Oliva, C., Roychowdhury, D., Paoletti, P., & Winer, E. P. (2009). Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clinical cancer research, 15(4), 1452-1459. doi:10.1158/1078-0432.CCR-08-1080